‘Coco’ filmmakers discover family history in latest Ancestry spot
Content Collective takes the Pixar film’s creators on their own genealogy journeys.
Genetic Testing
Ancestry’s first work from Droga5 makes a bold statement about America’s diversity
The genomics brand brings together 29 descendants of the founding fathers for an atypical July Fourth campaign.
23andMe partners with ‘Despicable Me 3’ for first movie partnership
The genetics testing company helps Gru find his lost-lost brother in six-week marketing push.
The Era of DTC Diagnostics, Diagnosis and Drug Development Is Here
Despite conventional wisdom that the 23andMe business breakthrough is the direct-to-consumer model, it’s also the consolidation of genetic testing, diagnosis and drug development that has the potential to change the industry.
Five things for pharma marketers to know: Wednesday, October 21, 2015
23andMe relaunches its DTC genetic test; Valeant’s woes increase as shares plummet; the FDA questions the safety of AstraZeneca’s gout drug
Five things for pharma marketers to know: Thursday, July 9
Pregnant women taking Prozac or Paxil have higher risks of birth defects; study finds J&J’s experimental psoriasis drug works better than Humira; AstraZeneca divests global rights to Entocort
Clinton tells pharma to explain drug prices
Speakers at Klick Health’s event criticized, lauded the role of technology in healthcare.
Five things for pharma marketers to know: Friday, May 15
Genentech alums launch a new biotechnology company; Mallinckrodt sues the FDA over a drug reclassification; Sanofi takes on celiac disease
Myriad expands companion diagnostic deals
The company partnered with AstraZeneca and BioMarin to identify which patients respond to experimental cancer drugs.
